Therefore, treatment with the T22-PE24-H6 nanotoxin could represent a promising tool for targeting CXCR4+ cancer stem cells and rendering sensitive the CRC tumors with acquired resistance to chemotherapy-induced apoptosis after their treatment, by inducing pyroptosis as an alternative cell death mechanism (Figure 5). The gene discussed is CXCR4; the disease is colorectal carcinoma.